BackLumos Pharma Overview

Lumos Pharma Long Term Debt

Latest long-term debt for LUMO: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-143000.00 vs prior year quarter

Peer average / median

Loading

Lumos Pharma Long Term Debt History

Loading

Lumos Pharma vs. peers: Long Term Debt Comparison

Loading

Lumos Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lumos Pharma (LUMO) FAQ

As of the most recent data (September 2024), LUMO shows a long-term debt of $0. That compares with $140K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LUMO's long-term debt is now $0 (was $140K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lumos Pharma is outperforming or lagging.

Tracking LUMO's long-term debt over time shows whether Lumos Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $140K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Lumos Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Lumos Pharma's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.